Table 3 Clinical response rates for the entire follow-up time and at the 12-months follow-up after treatment initiation
sJIA | Good response | Transient response | Poor response | |||
|---|---|---|---|---|---|---|
ANA | CANA | ANA | CANA | ANA | CANA | |
Twelve months | 79% (50/63) | 95% (21/22) | 21% (13/63) | 5% (1/22) | ||
Last follow-up | 68% (54/80) | 74% (20/27) | 5% (4/80) | 15% (4/27) | 27% (22/80) | 11% (3/27) |